Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis | Gastroenterología y Hepatología (English Edition)

Statistics

Special article

Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis

Nuevas dianas terapéuticas para el estudio de la enfermedad hepática crónica: la creación del Consorcio Iberoamericano para el estudio de la cirrosis hepática

Carlos Sanz-Garciaa, Yulia A. Nevzorovaa,b,c,d, Eduardo Martínez-Navesa,e, Francisco Javier Cuberoa,b,c,

Corresponding author

fcubero@ucm.es

Corresponding author.

, on behalf of the Iberoamerican Consortium for the study of liver Cirrhosis ◊

a Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain

b Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain

c Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

d Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany

e 12 de Octubre Health Research Institute (imas12), Madrid, Spain

Alejandro Hionides-Gutierrezaa, Jose Ramón Sañudoac, Carlos Enrichad, Carles Renteroad, Pau Sancho-Bruab,ad, Ricardo U. Macías-Rodriguezae, Astrid Ruiz-Margainae, David Kershenobich-Stalnikowitzae, Nestor R. Vargasaf,ag, Alberto E. Muñozaf,ag, Helder I. Nakayaah,ai

aa Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain

ab Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain

ac Department of Anatomy and Embriology, Complutense University School of Medicine, Madrid, Spain

ad Institut d’Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS Universitat de Barcelona, Barcelona, Spain

ae Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico

af Sección Hepatología, Hospital Dr. Carlos Bonorino Udaondo, Facultad de Medicina, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina

ag Instituto de Investigaciones en Salud Pública, Facultad de Odontología, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina

ah Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

ai Hospital Israelita Albert Einstein, São Paulo, Brazil

Read

510

Times
was read the article

174

Total PDF

336

Total HTML

Share statistics